Severe gastrointestinal bleeding in patients with locally advanced head and neck squamous cell carcinoma treated by concurrent radiotherapy and Cetuximab

被引:0
|
作者
Naoya Murakami
Seiichi Yoshimoto
Fumihiko Matsumoto
Takao Ueno
Yoshinori Ito
Satoru Watanabe
Kazuma Kobayashi
Ken Harada
Mayuka Kitaguchi
Shuhei Sekii
Kana Takahashi
Kotaro Yoshio
Koji Inaba
Madoka Morota
Minako Sumi
Yutaka Saito
Jun Itami
机构
[1] National Cancer Center Hospital,Department of Radiation Oncology
[2] National Cancer Center Hospital,Department of Head and Neck Surgery
[3] National Cancer Center Hospital,Department of Oral Health and Diagnostic Sciences
[4] National Cancer Center Hospital,Endoscopy Division
来源
Journal of Cancer Research and Clinical Oncology | 2015年 / 141卷
关键词
EGFR inhibitor; Cetuximab; Radiation therapy; Gastrointestinal bleeding; Adverse effect; Head and neck squamous cell carcinoma;
D O I
暂无
中图分类号
学科分类号
摘要
引用
收藏
页码:177 / 184
页数:7
相关论文
共 50 条
  • [1] Severe gastrointestinal bleeding in patients with locally advanced head and neck squamous cell carcinoma treated by concurrent radiotherapy and Cetuximab
    Murakami, Naoya
    Yoshimoto, Seiichi
    Matsumoto, Fumihiko
    Ueno, Takao
    Ito, Yoshinori
    Watanabe, Satoru
    Kobayashi, Kazuma
    Harada, Ken
    Kitaguchi, Mayuka
    Sekii, Shuhei
    Takahashi, Kana
    Yoshio, Kotaro
    Inaba, Koji
    Morota, Madoka
    Sumi, Minako
    Saito, Yutaka
    Itami, Jun
    JOURNAL OF CANCER RESEARCH AND CLINICAL ONCOLOGY, 2015, 141 (01) : 177 - 184
  • [2] Acute toxicity in 14 patients with locally advanced head and neck squamous cell carcinoma treated with concurrent cetuximab and radiotherapy
    Valeriani, M.
    Muni, R.
    Osti, M. F.
    De Sanctis, V.
    Minniti, G.
    Ardito, F.
    Enrici, R. Maurizi
    RADIOLOGIA MEDICA, 2012, 117 (01): : 125 - 132
  • [3] Concurrent cisplatin or cetuximab with radiotherapy in patients with locally advanced head and neck squamous cell carcinoma A meta-analysis
    Tang, Wen-Hua
    Sun, Wei
    Long, Guo-Xian
    MEDICINE, 2020, 99 (36)
  • [4] Hypofractionated radiotherapy combined with cetuximab in vulnerable elderly patients with locally advanced head and neck squamous cell carcinoma
    De Felice, Francesca
    Vetrone, Luigia
    Bulzonetti, Nadia
    Caiazzo, Rossella
    Marampon, Francesco
    Musio, Daniela
    Tombolini, Vincenzo
    MEDICAL ONCOLOGY, 2019, 36 (08)
  • [5] Cisplatin Versus Cetuximab With Radiotherapy in Locally Advanced Squamous Cell Carcinoma of the Head and Neck
    Husain, Zain A.
    Burtness, Barbara A.
    Decker, Roy H.
    JOURNAL OF CLINICAL ONCOLOGY, 2016, 34 (05) : 396 - +
  • [6] Hypofractionated radiotherapy combined with cetuximab in vulnerable elderly patients with locally advanced head and neck squamous cell carcinoma
    Francesca De Felice
    Luigia Vetrone
    Nadia Bulzonetti
    Rossella Caiazzo
    Francesco Marampon
    Daniela Musio
    Vincenzo Tombolini
    Medical Oncology, 2019, 36
  • [7] Management of dermatitis in patients with locally advanced squamous cell carcinoma of the head and neck receiving cetuximab and radiotherapy
    Cabezon Gutierrez, Luis
    Khosravi-Shahi, Parham
    Escobar Alvarez, Yolanda
    ORAL ONCOLOGY, 2012, 48 (04) : 293 - 297
  • [8] Concurrent Radiotherapy With Cetuximab or Platinum-based Chemotherapy for Locally Advanced Cutaneous Squamous Cell Carcinoma of the Head and Neck
    Lu, Sharon M.
    Lien, Winston W.
    AMERICAN JOURNAL OF CLINICAL ONCOLOGY-CANCER CLINICAL TRIALS, 2018, 41 (01): : 95 - 99
  • [9] Toxicity of cetuximab versus cisplatin concurrent with radiotherapy in locally advanced head and neck squamous cell cancer (LAHNSCC)
    Walsh, Lorraine
    Gillham, Charles
    Dunne, Mary
    Fraser, Ian
    Hollywood, Donal
    Armstrong, John
    Thirion, Pierre
    RADIOTHERAPY AND ONCOLOGY, 2011, 98 (01) : 38 - 41
  • [10] Hypofractionated Accelerated Radiotherapy with Concurrent Carboplatin for Locally Advanced Squamous Cell Carcinoma of the Head and Neck
    Chan, A. K.
    Sanghera, P.
    Choo, B. A.
    McConkey, C.
    Mehanna, H.
    Parmar, S.
    Pracy, P.
    Glaholm, J.
    Hartley, A.
    CLINICAL ONCOLOGY, 2011, 23 (01) : 34 - 39